The Global ofloxacin eye drops market is estimated to grow at a significant CAGR during the forecast period. Ofloxacin is used to treat infections in the eyes. Ofloxacin is a quinolone antibiotic, which means it belongs to a group of antibiotics known as quinolones. It works by preventing bacteria from growing. Only bacterial eye infections are treated with this drug. According to the WHO, trachoma is common among preschool-aged children, with prevalence rates which can be as high as 60 to 90%. Infection becomes less frequent and shorter in duration with increasing age.
A full report of Ofloxacin eye drops Market is available at: https://www.omrglobal.com/industry-reports/ofloxacin-eye-drops-market
Ofloxacin is a fluoroquinolone, which means it is a synthetic broad – spectrum antibiotic. Ofloxacin is used to prevent the development of antibiotic resistance and to keep antibacterial drugs effective. This drug should only be used to treat or prevent infections caused by susceptible bacteria that have been proved or highly suspected. Ofloxacin’s benefits include excellent oral absorption, easier tissue penetration, and easier once- or twice-daily dosage, as well as broad range action against many pathogenic bacterial strains. The growth of different mutant bacterial strains around the globe, as well as the rising prevalence of infectious disease, are important factors driving the growth of the Ofloxacin eye drop Market. Furthermore, the rising prevalence of multi-drug resistant bacteria, resulting in increased health concerns, is fueling the growth of the Ofloxacin eye drop Market. Fluoroquinolones may be able to partially replace other dugs treatments due to their various advantages over other antibacterial drugs
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/ofloxacin-eye-drops-market
Around 65 to 90% of cases are caused by adenovirus. Occasionally, herpes simplex or zoster virus is responsible. According to NCBI, Viral conjunctivitis is the most common cause of infectious conjunctivitis. This infection is more common in adults than in children.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segmentation Covered
o By Type
o By Application
- Region covered
o North America
o Europe
o Asia-Pacific
o Rest of the world
- Competitive Landscape- Novartis AG., Allergan, Inc., Meda Pharmaceuticals Inc., Bausch & Lomb Inc., Cigna., and Similasan Corporation., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominates the market in base year?
- Which segment and region will project fastest growth in the market?
- How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Market Segmentation
By Type
- Opthalmic surgery
- Anti- inflammatory
By Application
- Adult
- Children
Company Profiles
- Novartis AG.
- Allergan, Inc.
- Meda Pharmaceuticals Inc.
- Bausch & Lomb Inc.
- Similasan Corporation.
This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.
